Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bauhinia Forficata Extract in Diabetic Patients
NCT02760017Completed
- Sponsor
- Universidade do Extremo Sul Catarinense
- Start
- Apr 2016
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of Bauhinia forficata in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Universidade do Extremo Sul Catarinense. Primary endpoints: Glycated hemoglobin levels at 4 months and Fasting glucose levels at 4 months. Started Apr 2016; status: completed.
02
Drugs
Bauhinia forficata
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02760017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02760017.